Aura Biosciences (AURA) Cash from Operations (2020 - 2026)
Aura Biosciences' (AURA) quarterly Cash from Operations came in at 29893000.0 in Q1 2026, down 27.99% YoY from 41514599.22 in Q1 2025, and down 46.34% on a QoQ basis from 20427000.0 in Q4 2025.
Aura Biosciences (AURA) Cash from Operations (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Cash from Operations data on file, last reported at 29893000.0 in Q1 2026.
- Quarterly Cash from Operations fell 27.99% year-over-year to 29893000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91238000.0 (down 15.92% YoY) and the FY2025 annual result came in at 84700000.0, down 6.13% from the prior year.
- Cash from Operations retreated to 29893000.0 in Q1 2026, from 20427000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 10628000.0 in Q2 2022 to a low of 29893000.0 in Q1 2026.
- A 5-year average of 18402705.88 and a median of 17387000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 195.89% — and 2025, when it climbed 14.72%.
- Tracing AURA's Cash from Operations over 5 years: stood at 18013000.0 in 2022, then increased by 3.48% to 17387000.0 in 2023, then slumped by 37.76% to 23952000.0 in 2024, then rose by 14.72% to 20427000.0 in 2025, then plunged by 46.34% to 29893000.0 in 2026.
- The last three Cash from Operations figures came in at 29893000.0 (Q1 2026), 20427000.0 (Q4 2025), and 20144000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | -32.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.50 Mn |
| Jun 30, 2026 | -32.50 Mn |
| Mar 31, 2026 | -29.89 Mn |
| Mar 31, 2026 | -29.89 Mn |
| Dec 31, 2025 | -20.43 Mn |
| Dec 31, 2025 | -20.43 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Jun 30, 2025 | -20.77 Mn |
| Jun 30, 2025 | -20.77 Mn |
| Mar 31, 2025 | -23.36 Mn |
| Mar 31, 2025 | -23.36 Mn |
| Dec 31, 2024 | -23.95 Mn |
| Dec 31, 2024 | -23.95 Mn |
| Sep 30, 2024 | -15.27 Mn |
| Sep 30, 2024 | -15.27 Mn |
| Jun 30, 2024 | -16.13 Mn |
| Jun 30, 2024 | -16.13 Mn |
| Mar 31, 2024 | -24.45 Mn |
| Mar 31, 2024 | -24.45 Mn |